scispace - formally typeset
G

Gail V.W. Johnson

Researcher at University of Rochester

Publications -  257
Citations -  31228

Gail V.W. Johnson is an academic researcher from University of Rochester. The author has contributed to research in topics: Tissue transglutaminase & Tau protein. The author has an hindex of 78, co-authored 250 publications receiving 27471 citations. Previous affiliations of Gail V.W. Johnson include University of Rochester Medical Center & University of Alabama.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy

Daniel J. Klionsky, +1287 more
- 01 Apr 2012 - 
TL;DR: These guidelines are presented for the selection and interpretation of methods for use by investigators who aim to examine macroautophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

The glamour and gloom of glycogen synthase kinase-3.

Richard S. Jope, +1 more
- 01 Feb 2004 - 
TL;DR: Much effort is currently directed towards understanding the functions and control of GSK3, and identifying methods capable of diminishing the deleterious impact of G SK3 in pathological conditions.
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)

Daniel J. Klionsky, +2983 more
- 08 Feb 2021 - 
TL;DR: In this article, the authors present a set of guidelines for investigators to select and interpret methods to examine autophagy and related processes, and for reviewers to provide realistic and reasonable critiques of reports that are focused on these processes.
Journal ArticleDOI

Prasugrel versus clopidogrel for acute coronary syndromes without revascularization

Matthew T. Roe, +1038 more
- 03 Oct 2012 - 
TL;DR: Among patients with unstable angina or myocardial infarction without ST-segment elevation, prasugrel did not significantly reduce the frequency of the primary end point, as compared with clopidogrel, and similar risks of bleeding were observed.